Atara Biotherapeutics (ATRA): Officer filed to sell ~$735
Nguyen AnhCo, Officer at Atara Biotherapeutics, filed to sell ~$735 of Atara Biotherapeutics shares.
- ~$735
- planned to sell · 113 shares, around Nov 17, 2026
- Planned for
- Nov 17, 2026
- Notice filed
- Nov 17, 2026
What stands out in this filing
- The planned sale is less than 0.01% of the company's shares outstanding.
- How the shares were acquired, per the notice: Settlement of vested RSUs issued under an S-8 Registration Plan.
- The notice says the shares were received as pay (stock awards or options).
- Broker named on the notice: Morgan Stanley Smith Barney LLC.
- Remarks on the notice: Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
- A Form 144 announces a sale; the Form 4 that follows shows whether it took place, at what price.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
How to read SEC Form 144
Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.
Full guide: What is an SEC Form 144?
What else is on file for Atara Biotherapeutics
For Atara Biotherapeutics, OQRO holds 5 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ATRA page.
How this filing works
Explore the data
Common questions
Which Atara Biotherapeutics (ATRA) insider traded, and how much?
Nguyen AnhCo, Officer at Atara Biotherapeutics, filed to sell ~$735 of Atara Biotherapeutics shares. 113 shares, Form 144 notice of a planned sale.
When did it happen, and when was it made public?
Planned for: Nov 17, 2026. Notice filed: Nov 17, 2026.
What stands out in this filing?
The planned sale is less than 0.01% of the company's shares outstanding. How the shares were acquired, per the notice: Settlement of vested RSUs issued under an S-8 Registration Plan. The notice says the shares were received as pay (stock awards or options).
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 144, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Atara Biotherapeutics recently?
For Atara Biotherapeutics, OQRO holds 5 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the ATRA page.
Does this mean ATRA stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Atara Biotherapeutics
- SEC Form 4Nov 18, 2026
- SEC Form 144Nov 16, 2026
- SEC Form 4Sep 4, 2026
- SEC Form 4Aug 26, 2026
- SEC Form 4May 20, 2026
- SEC Form 4May 20, 2026
Everything OQRO holds on this company is on its ATRA page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
